Company: VMCWF
Filing Date: 2025-03-31
Form Type: 10-K
Source: 0001641172-25-001827
Chunk: 60

Company: Valuence Merger Corp. I
Filing Date: 2025-03-31
Form: 10-K
Item: Item 1
Chunk 60
---
 operations.

Although
we expect to focus our search for a suitable initial Business Combination with companies that are either developing breakthrough technology
in life sciences or advancing a platform for sustainable technology, we may pursue acquisition opportunities in any one of numerous industries,
except that we will not, under our Articles, be permitted to effectuate our Business Combination with another blank check company or
similar company with nominal operations. Because we have not yet identified any specific target business with respect to a Business Combination,
there is no basis to evaluate the possible merits or risks of any particular target business’ operations, results of operations,
cash flows, liquidity, financial condition or prospects.

To
the extent we complete our Business Combination, we may be affected by numerous risks inherent in the business operations with which
we combine. For example, if we combine with a financially unstable business or an entity lacking an established record of sales or earnings,
we may be affected by the risks inherent in the business and operations of a financially unstable or an early stage entity. Although
our officers and directors will endeavor to evaluate the risks inherent in a particular target business, we cannot assure you that we
will properly ascertain or assess all of the significant risk factors or that we will have adequate time to complete due diligence. Furthermore,
some of these risks may be outside of our control and leave us with no ability to control or reduce the chances that those risks will
adversely impact a target business. We also cannot assure you that an investment in our securities will ultimately prove to be more favorable
to investors than a direct investment, if such opportunity were available, in a target. Accordingly, any shareholders who choose to remain
shareholders following the Business Combination could suffer a reduction in the value of their shares. Such shareholders are unlikely
to have a remedy for such reduction in value unless they are able to successfully claim that the reduction was due to the breach by our
officers or directors of a duty of care or other fiduciary duty owed to them, or if they are able to successfully bring a private claim
under securities laws that the tender offer materials or proxy statement relating to the Business Combination contained an actionable
material misstatement or material omission.

32

We
may seek acquisition opportunities in industries or sectors that may be outside of our management’s areas of expertise.

We
will consider a Business Combination outside of our management’s areas of expertise if a Business Combination candidate is presented
to us and we determine that such candidate offers an attractive acquisition opportunity for our Company. In the event we elect to pursue